Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
about
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesSignificance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura.Stem cell transplantation for muscular dystrophy: the challenge of immune response.CD40 is expressed and functional on neuronal cellsInflammatory myopathies: clinical, diagnostic and therapeutic aspects.Pathogenesis of dermatomyositis: role of cytokines and interferon.Premature labor: a state of platelet activation?The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositisCytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemiaCombination of inflammation-related cytokines promotes long-term muscle stem cell expansion.Expression of interleukin-15 in mouse and human atherosclerotic lesions.The role of CD40 ligand in systemic lupus erythematosus.Targeting CD40L: a promising therapeutic approach.Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis.Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.Cytokines in idiopathic inflammatory myopathies.Pathogenesis of idiopathic inflammatory myopathies.Role of CD40 in prion disease and the immune response to recombinant PrPImmune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.Advances in the immunobiology and treatment of inflammatory myopathies.Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.Immunopathogenesis of juvenile dermatomyositis.Targeted immunotherapy trials for idiopathic inflammatory myopathies.Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies.A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.Immunological biomarkers in dermatomyositis.Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism.Modulation of neuronal differentiation by CD40 isoforms.Endurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis.Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo.[New aspects on the pathogenesis of myositis].The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.
P2860
Q26798209-4EB3A57C-1C0B-499E-B128-27D24BF4C617Q33345510-B70266BE-F36C-4B46-84C9-6AC4E82DBFFCQ33902416-E6C839BA-E2F9-4421-A128-B8CF0D0D0ABCQ34085854-C19900EA-E09D-4635-8833-7502202FE2B4Q34186450-8C5CE3CB-0C89-4ED2-B737-D96E0F4EF2F8Q34626955-BA9467CE-6F4D-4164-A6C1-F23BD908C762Q35185510-3B1373A4-9238-46E5-B86C-4F7089529038Q35450066-B9CCD7A8-1358-4E30-A044-E063395219A7Q35554845-BD3FE49D-BCE4-42DC-A8DD-7B77D6B1DD1AQ35593441-66D23DD3-BAA9-4E51-83CB-5B7FB2AD7DEEQ35610286-BC0A0C5F-4957-4768-A3CD-277348D12286Q35651700-F1B75E49-C3CB-42BA-A9D5-BD23BE2B02D4Q35686082-2EF661B6-B52E-49AD-A44C-863F91851B7FQ35747016-C6EB2570-A7EE-40DF-8469-E29DCC521136Q35824522-C61C1FB3-DC21-45B1-AAD8-52E78F4E47C9Q35830859-66D895FB-B669-4F99-9E4F-D43A76546531Q36096978-7AD718CA-AB2D-4851-84CD-3BFB61192BBEQ36242892-AB12DEA6-68CC-4334-A53E-1DEB574C1E94Q36504371-86F64CC7-EBA3-4F46-84AA-8AFB7ABE3935Q36562010-D272A78A-3104-46E8-92CE-EAD001CF77E8Q36747148-559303FC-65E4-465A-B1AA-283D813F2848Q36771917-2D139E36-5208-455E-929B-E48423DFFA43Q36905991-9A8A0CFB-649E-437F-966F-7EDA9B8F5DC6Q37396900-EE99E7CE-A8E3-451D-A468-088AF41C728BQ37734332-A22508B0-84D1-4480-9DAE-9EDEA56AA33CQ38023207-4B4A38D9-743E-44CA-9886-3586560D43BDQ38089081-1BC30FA0-1174-460C-96A2-BBC63EE3AEDBQ38303947-EC8C245A-00E9-4DA9-A5BE-624479CFC1BFQ38592676-1175B668-F227-425C-A0D2-DFE2D8311317Q38763290-92820F64-6E52-4B80-8A24-8A6D612FD4EEQ39991745-A1B3DAD8-6842-4DDA-878F-218AB56EC5CBQ40004698-A3E662FC-D45D-4BEF-87A0-9C526769C7F1Q43269358-1DD7B8D0-9E49-483C-8F88-10B6CCCF4684Q43978656-AF459FA4-380D-4AA3-AA4F-21BE2291BDE3Q44847724-B643C9C1-0B6E-490D-9DBF-73BF42CAD832
P2860
Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Increased CD40 expression on m ...... tractant protein-1 production.
@en
type
label
Increased CD40 expression on m ...... tractant protein-1 production.
@en
prefLabel
Increased CD40 expression on m ...... tractant protein-1 production.
@en
P2093
P1476
Increased CD40 expression on m ...... tractant protein-1 production.
@en
P2093
Fukasawa C
Kamatani N
Kawaguchi Y
P304
P356
10.4049/JIMMUNOL.164.12.6593
P407
P577
2000-06-01T00:00:00Z